StrategicAccountManager

ABOUT US There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers. At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U. S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19. Be part of making a difference. Be part of Invivyd. Location: Remote (Los Angeles) Position Summary: At Invivyd, we’re building a new category of infectious disease prevention. With an authorized product already on the market, a next-generation program in Phase 3 and a strong pipeline behind it, we are at a defining moment of growth. We have an exciting opportunity for a Strategic Account Manager who will play a pivotal role at Invivyd. This is an incredible opportunity for someone who is passionate about making a difference for patients, executing successful sales strategies and supporting a culture of adaptability and compliance. In this role, you will lead strategic territory planning, cultivate high-value partnerships across key accounts, and deliver clear, compliant education on approved messaging to diverse healthcare stakeholde